1) Pyridoxine dipalmitate
吡多素二棕榈酸酯
2) 5-Hydroxy-6-methyl-3,4-pyridinedimethanol dipalmitate
吡哆醇二棕榈酸酯
3) kojic dipalmitate
曲酸二棕榈酸酯
1.
The result is kojic dipalmitate offers the best overall performance.
比较了４ 种皮肤美白剂的作用机理； 配方的难易及稳定性； 安全性及有效性； 功能性及适应性， 得出结果以曲酸二棕榈酸酯效果最佳。
2.
Objective Using azobenzene-N-succinyl chitosan polymer and azobenzene-chitosan polymer as main light intelligent carriers, intelligent drug delivery system of light sensitive hydrogel loaded kojic dipalmitate was studied in the first time.
目的首次以曲酸二棕榈酸酯为模型药物,偶氮苯-N-琥珀酰壳聚糖聚合物和偶氮苯-壳聚糖聚合物为主要光敏感性智能载体,研究曲酸二棕榈酸酯光敏感性水凝胶智能给药系统。
4) vitamin A plamitate
维生素A棕榈酸酯
1.
Novozym 435 was used for the synthesis of vitamin A plamitate.
对催化合成维生素A棕榈酸酯反应的脂肪酶和反应介质进行了比较,同时对影响合成维生素A棕榈酸酯反应的因素(温度、初始水含量、底物摩尔比、反应时间和酶量等)进行了探讨,优化了反应条件:在10mL不含水分的正己烷中,0。
2.
The synthesis of vitamin A plamitate in organic solvent with vitamin A acetate and ethyl palmitate with immobilized lipase from Candida sp.
研究了有机溶剂中脂肪酶催化维生素A棕榈酸酯的合成工艺。
5) retinol palmitate
维生素A棕榈酸酯
1.
A nonaqueousRP-HPLC method for determination of retinol palmitate, ergocalciferol, vitamin E acetate and phytonadione was established.
建立了非水反相高效液相色谱法同时测定4种脂溶性维生素——维生素A棕榈酸酯、维生素D2、维生素E醋酸酯、维生素K1的含量。
2.
Objective: To establish nonaqueous RP-HPLC to determine retinol palmitate、colecalciferol and vitamin E acetate in multi-vitamin injection simultaneously.
目的:用非水反相高效液相色谱法建立复合维生素注射液中维生素A棕榈酸酯、维生素D3和维生素E醋酸酯的含量测定方法。
3.
OBJECTIVE To establish an HPLC method for simultaneous determination of retinol palmitate,vitamin D2, vitamin E and vitamin K1 in fat-soluble vitamin for injection.
目的建立高效液相色谱法同时测定注射用脂溶性维生素中维生素A棕榈酸酯、维生素D2、E、K1含量的方法。
6) Vitamin A palmitate
维生素A棕榈酸酯
1.
RESULTS: The linear ranges of Vitamin D2, Vitamin E acetic ester and Vitamin A palmitate were 0.
结果:维生素D2、维生素E醋酸酯与维生素A棕榈酸酯检测浓度的线性范围分别为0。
2.
The aim was to prepare a novel ocular cationic microemulsion-in situ gel(CM-ISG) system with vitamin A palmitate (VAP) as model drug,and investigate the corneal retention behavior and corneal irritation of the system.
设计了新型眼用阳离子微乳-原位凝胶(cationic microemulsion-in situgel,CM-ISG)系统,以维生素A棕榈酸酯(vitamin A palmitate,VAP)为模型药物研究了该释药系统的角膜滞留特性,并评价了角膜刺激性。
补充资料：吡多素二棕榈酸酯
分子式：C40H71NO5
分子量：646.00
CAS号：635-38-1
性质：熔点87-91°C。
分子量：646.00
CAS号：635-38-1
性质：熔点87-91°C。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条